Benefit of continuous treatment for responders with newly diagnosed multiple myeloma in the randomized FIRST trial View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2017-11

AUTHORS

N J Bahlis, A Corso, L-O Mugge, Z-X Shen, P Desjardins, A-M Stoppa, O Decaux, T de Revel, M Granell, G Marit, H Nahi, H Demuynck, S-Y Huang, S Basu, T H Guthrie, A Ervin-Haynes, J Marek, G Chen, T Facon

ABSTRACT

The phase 3, randomized Frontline Investigation of Revlimid and Dexamethasone Versus Standard Thalidomide (FIRST) trial investigating lenalidomide plus low-dose dexamethasone until disease progression (Rd continuous) vs melphalan, prednisone and thalidomide for 12 cycles (MPT) and Rd for 18 cycles (Rd18) in transplant-ineligible patients with newly diagnosed multiple myeloma (NDMM) showed that Rd continuous prolonged progression-free survival and overall survival compared with MPT. A subanalysis of the FIRST trial was conducted to determine the benefits of Rd continuous in patients with NDMM based on depth of response. Patients randomized 1:1:1 to Rd continuous, Rd18 or MPT were divided into subgroups based on best response: complete response (CR; n=290), ⩾very good partial response (VGPR; n=679), ⩾partial response (PR; n=1 225) or ⩽stable disease (n=299). Over 13% of patients receiving Rd continuous who achieved ⩾VGPR as best response did so beyond 18 months of treatment. Rd continuous reduced the risk of progression or death by 67%, 51% and 35% vs MPT in patients with CR, ⩾VGPR and ⩾PR, respectively. Similarly, Rd continuous reduced the risk of progression or death by 61%, 54% and 38% vs Rd18 in patients with CR, ⩾VGPR and ⩾PR, respectively. In patients with CR, ⩾VGPR or ⩾PR, 4-year survival rates in the Rd continuous arm (81.1%, 73.1% or 64.6%, respectively) were higher vs MPT (70.8%, 59.8% or 57.2%, respectively) and similar vs Rd18 (76.5%, 67.7% and 62.5%, respectively). Rd continuous improved efficacy outcomes in all responding patients, including those with CR, compared with fixed duration treatment. More... »

PAGES

2435

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/leu.2017.111

DOI

http://dx.doi.org/10.1038/leu.2017.111

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1084510691

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/28373701


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dexamethasone", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Melphalan", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Multiple Myeloma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prednisone", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Thalidomide", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Alberta Health Services", 
          "id": "https://www.grid.ac/institutes/grid.413574.0", 
          "name": [
            "Tom Baker Cancer Center-University of Calgary, Calgary, Alberta, Canada."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bahlis", 
        "givenName": "N J", 
        "id": "sg:person.01012164172.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01012164172.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Pavia", 
          "id": "https://www.grid.ac/institutes/grid.8982.b", 
          "name": [
            "Policlinico San Matteo Universita Di Pavia, Pavia, Italy."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Corso", 
        "givenName": "A", 
        "id": "sg:person.0765250665.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0765250665.41"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Jena University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.275559.9", 
          "name": [
            "Universit\u00e4tsklinikum Jena Klinik f\u00fcr Innere Medizin II, Jena, Germany."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mugge", 
        "givenName": "L-O", 
        "id": "sg:person.0771317052.95", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0771317052.95"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Shanghai Jiao Tong University", 
          "id": "https://www.grid.ac/institutes/grid.16821.3c", 
          "name": [
            "Ruijin Hospital, Shanghai Jiao Tong University, Shanghai, China."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shen", 
        "givenName": "Z-X", 
        "id": "sg:person.0600616433.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0600616433.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hopital Charles-LeMoyne", 
          "id": "https://www.grid.ac/institutes/grid.420748.d", 
          "name": [
            "H\u00f4pital Charles LeMoyne, Longueuil, Canada."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Desjardins", 
        "givenName": "P", 
        "id": "sg:person.01002216441.96", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01002216441.96"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute Paoli-Calmettes", 
          "id": "https://www.grid.ac/institutes/grid.418443.e", 
          "name": [
            "Institut Paoli Calmettes, Marseille, France."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Stoppa", 
        "givenName": "A-M", 
        "id": "sg:person.015101675464.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015101675464.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "CHRU H\u00f4pital Sud M\u00e9decine Interne, Rennes, France."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Decaux", 
        "givenName": "O", 
        "id": "sg:person.01276375576.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01276375576.23"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "H\u00f4pital d'instruction des Arm\u00e9es Percy", 
          "id": "https://www.grid.ac/institutes/grid.414028.b", 
          "name": [
            "H\u00f4pital d'Instruction des Arm\u00e9es PERCY, Paris, France."
          ], 
          "type": "Organization"
        }, 
        "familyName": "de Revel", 
        "givenName": "T", 
        "id": "sg:person.01246300414.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01246300414.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hospital de Sant Pau", 
          "id": "https://www.grid.ac/institutes/grid.413396.a", 
          "name": [
            "Hospital de la Santa Creu i Sant Pau, Barcelona, Spain."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Granell", 
        "givenName": "M", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre Hospitalier Universitaire de Bordeaux", 
          "id": "https://www.grid.ac/institutes/grid.42399.35", 
          "name": [
            "CHRU H\u00f4pital du Haut L\u00e9v\u00eaque, CHU de Bordeaux, Pessac, France."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Marit", 
        "givenName": "G", 
        "id": "sg:person.0663277537.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0663277537.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Karolinska University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.24381.3c", 
          "name": [
            "Karolinska University Hospital, Huddinge, Sweden."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nahi", 
        "givenName": "H", 
        "id": "sg:person.01346655130.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01346655130.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "H. Hart Ziekenhuis Roeselare-Menen, Roeselare, Belgium."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Demuynck", 
        "givenName": "H", 
        "id": "sg:person.016613112373.61", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016613112373.61"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National Taiwan University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.412094.a", 
          "name": [
            "National Taiwan University Hospital, Taipei City, Taiwan."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Huang", 
        "givenName": "S-Y", 
        "id": "sg:person.016600345354.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016600345354.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "New Cross Hospital", 
          "id": "https://www.grid.ac/institutes/grid.416051.7", 
          "name": [
            "New Cross Hospital, Wolverhampton, UK."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Basu", 
        "givenName": "S", 
        "id": "sg:person.01031540525.68", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01031540525.68"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "21st Century Oncology (United States)", 
          "id": "https://www.grid.ac/institutes/grid.476819.5", 
          "name": [
            "21st Century Oncology, Jacksonville, FL, USA."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Guthrie", 
        "givenName": "T H", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Celgene (United States)", 
          "id": "https://www.grid.ac/institutes/grid.418722.a", 
          "name": [
            "Celgene Corporation, Summit, NJ, USA."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ervin-Haynes", 
        "givenName": "A", 
        "id": "sg:person.0611013300.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0611013300.29"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Celgene (United States)", 
          "id": "https://www.grid.ac/institutes/grid.418722.a", 
          "name": [
            "Celgene Corporation, Summit, NJ, USA."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Marek", 
        "givenName": "J", 
        "id": "sg:person.0742510353.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0742510353.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Celgene (United States)", 
          "id": "https://www.grid.ac/institutes/grid.418722.a", 
          "name": [
            "Celgene Corporation, Summit, NJ, USA."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chen", 
        "givenName": "G", 
        "id": "sg:person.0760250477.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0760250477.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "H\u00f4pital Claude Huriez", 
          "id": "https://www.grid.ac/institutes/grid.413875.c", 
          "name": [
            "Service des Maladies du Sang, H\u00f4pital Claude Huriez, CHRU Lille, Lille, France."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Facon", 
        "givenName": "T", 
        "id": "sg:person.01125032152.62", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01125032152.62"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.3816/clml.2010.n.120", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013210054"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/leu.2013.220", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017507834", 
          "https://doi.org/10.1038/leu.2013.220"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2009-03-211953", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019111246"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2010-09-307645", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019656561"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/leusup.2013.5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025142681", 
          "https://doi.org/10.1038/leusup.2013.5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2013.49.0086", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026808845"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.23546", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031068927"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3324/haematol.2009.015917", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031130867"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.leu.2404284", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033553106", 
          "https://doi.org/10.1038/sj.leu.2404284"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.leu.2404284", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033553106", 
          "https://doi.org/10.1038/sj.leu.2404284"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/leu.2010.313", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034730993", 
          "https://doi.org/10.1038/leu.2010.313"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(07)61537-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037699397"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2008.21.0948", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040245441"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1155/2014/456037", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041179576"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2014-01-550020", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041943451"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2011-02-338665", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042868402"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa0801479", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043382081"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1402551", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048449895"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2012.41.6180", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048463328"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.6004/jnccn.2013.0007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078673181"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.6004/jnccn.2013.0007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078673181"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2017-11", 
    "datePublishedReg": "2017-11-01", 
    "description": "The phase 3, randomized Frontline Investigation of Revlimid and Dexamethasone Versus Standard Thalidomide (FIRST) trial investigating lenalidomide plus low-dose dexamethasone until disease progression (Rd continuous) vs melphalan, prednisone and thalidomide for 12 cycles (MPT) and Rd for 18 cycles (Rd18) in transplant-ineligible patients with newly diagnosed multiple myeloma (NDMM) showed that Rd continuous prolonged progression-free survival and overall survival compared with MPT. A subanalysis of the FIRST trial was conducted to determine the benefits of Rd continuous in patients with NDMM based on depth of response. Patients randomized 1:1:1 to Rd continuous, Rd18 or MPT were divided into subgroups based on best response: complete response (CR; n=290), \u2a7every good partial response (VGPR; n=679), \u2a7epartial response (PR; n=1 225) or \u2a7dstable disease (n=299). Over 13% of patients receiving Rd continuous who achieved \u2a7eVGPR as best response did so beyond 18 months of treatment. Rd continuous reduced the risk of progression or death by 67%, 51% and 35% vs MPT in patients with CR, \u2a7eVGPR and \u2a7ePR, respectively. Similarly, Rd continuous reduced the risk of progression or death by 61%, 54% and 38% vs Rd18 in patients with CR, \u2a7eVGPR and \u2a7ePR, respectively. In patients with CR, \u2a7eVGPR or \u2a7ePR, 4-year survival rates in the Rd continuous arm (81.1%, 73.1% or 64.6%, respectively) were higher vs MPT (70.8%, 59.8% or 57.2%, respectively) and similar vs Rd18 (76.5%, 67.7% and 62.5%, respectively). Rd continuous improved efficacy outcomes in all responding patients, including those with CR, compared with fixed duration treatment.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/leu.2017.111", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1097065", 
        "issn": [
          "0887-6924", 
          "1476-5551"
        ], 
        "name": "Leukemia", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "11", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "31"
      }
    ], 
    "name": "Benefit of continuous treatment for responders with newly diagnosed multiple myeloma in the randomized FIRST trial", 
    "pagination": "2435", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "4089e22ad7cc52bd30cd0a1a07b12bd9a145a3a59ad5fca73610cf93390e5a60"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "28373701"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8704895"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/leu.2017.111"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1084510691"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/leu.2017.111", 
      "https://app.dimensions.ai/details/publication/pub.1084510691"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T17:19", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8672_00000422.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://www.nature.com/articles/leu2017111"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/leu.2017.111'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/leu.2017.111'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/leu.2017.111'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/leu.2017.111'


 

This table displays all metadata directly associated to this object as RDF triples.

352 TRIPLES      21 PREDICATES      61 URIs      34 LITERALS      22 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/leu.2017.111 schema:about N02a29daadbf3432797fd4b78d4d81948
2 N06f8e752619e49f98b8f51507550aabb
3 N0fc502e1ef6c4cc2acce8c6461b66981
4 N439ea8fc71324ba9aef9fc0677e3727b
5 N4b4154c2bc7347a1ad47c0473fcbbfcd
6 N6382018fb4f246e3a613fd414f5e3ab8
7 N76b8fbbb00c34679b98400fb5206fd52
8 N8f8c9206637f4af99686b3ddd9bcb44f
9 N971a3cfd00174c1180c10d20419ea975
10 N99501b32feb64f23b94a6fe0e969f89b
11 N9db5f6a482db4c988bc4956178b63218
12 N9de890d48b5d4266a6f5923471ce44b4
13 Ndc4c35eb54b24b97b657e13a583c6ba9
14 anzsrc-for:11
15 anzsrc-for:1103
16 schema:author N5fb710815e77499ba0e9df74e0761a2f
17 schema:citation sg:pub.10.1038/leu.2010.313
18 sg:pub.10.1038/leu.2013.220
19 sg:pub.10.1038/leusup.2013.5
20 sg:pub.10.1038/sj.leu.2404284
21 https://doi.org/10.1002/cncr.23546
22 https://doi.org/10.1016/s0140-6736(07)61537-2
23 https://doi.org/10.1056/nejmoa0801479
24 https://doi.org/10.1056/nejmoa1402551
25 https://doi.org/10.1155/2014/456037
26 https://doi.org/10.1182/blood-2009-03-211953
27 https://doi.org/10.1182/blood-2010-09-307645
28 https://doi.org/10.1182/blood-2011-02-338665
29 https://doi.org/10.1182/blood-2014-01-550020
30 https://doi.org/10.1200/jco.2008.21.0948
31 https://doi.org/10.1200/jco.2012.41.6180
32 https://doi.org/10.1200/jco.2013.49.0086
33 https://doi.org/10.3324/haematol.2009.015917
34 https://doi.org/10.3816/clml.2010.n.120
35 https://doi.org/10.6004/jnccn.2013.0007
36 schema:datePublished 2017-11
37 schema:datePublishedReg 2017-11-01
38 schema:description The phase 3, randomized Frontline Investigation of Revlimid and Dexamethasone Versus Standard Thalidomide (FIRST) trial investigating lenalidomide plus low-dose dexamethasone until disease progression (Rd continuous) vs melphalan, prednisone and thalidomide for 12 cycles (MPT) and Rd for 18 cycles (Rd18) in transplant-ineligible patients with newly diagnosed multiple myeloma (NDMM) showed that Rd continuous prolonged progression-free survival and overall survival compared with MPT. A subanalysis of the FIRST trial was conducted to determine the benefits of Rd continuous in patients with NDMM based on depth of response. Patients randomized 1:1:1 to Rd continuous, Rd18 or MPT were divided into subgroups based on best response: complete response (CR; n=290), ⩾very good partial response (VGPR; n=679), ⩾partial response (PR; n=1 225) or ⩽stable disease (n=299). Over 13% of patients receiving Rd continuous who achieved ⩾VGPR as best response did so beyond 18 months of treatment. Rd continuous reduced the risk of progression or death by 67%, 51% and 35% vs MPT in patients with CR, ⩾VGPR and ⩾PR, respectively. Similarly, Rd continuous reduced the risk of progression or death by 61%, 54% and 38% vs Rd18 in patients with CR, ⩾VGPR and ⩾PR, respectively. In patients with CR, ⩾VGPR or ⩾PR, 4-year survival rates in the Rd continuous arm (81.1%, 73.1% or 64.6%, respectively) were higher vs MPT (70.8%, 59.8% or 57.2%, respectively) and similar vs Rd18 (76.5%, 67.7% and 62.5%, respectively). Rd continuous improved efficacy outcomes in all responding patients, including those with CR, compared with fixed duration treatment.
39 schema:genre research_article
40 schema:inLanguage en
41 schema:isAccessibleForFree true
42 schema:isPartOf N0c81fe5f44444da2be14167521e50ce2
43 N76ab5481ae1f40e78923757cb77e8cde
44 sg:journal.1097065
45 schema:name Benefit of continuous treatment for responders with newly diagnosed multiple myeloma in the randomized FIRST trial
46 schema:pagination 2435
47 schema:productId N23f0c7e8081d4ae4903d8855318c6596
48 N42c439ffbe5b4cb9ac9319897ebc9e4f
49 N4c3717fe86524ef4a0e364e14f9af2a1
50 N4e3ea0f23d374daea2add26261e70e34
51 N7d6dc5bdd7a7490e8eee0512bc1c7b86
52 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084510691
53 https://doi.org/10.1038/leu.2017.111
54 schema:sdDatePublished 2019-04-10T17:19
55 schema:sdLicense https://scigraph.springernature.com/explorer/license/
56 schema:sdPublisher Nfcd42e26276e4a8281b0842f99cf6402
57 schema:url https://www.nature.com/articles/leu2017111
58 sgo:license sg:explorer/license/
59 sgo:sdDataset articles
60 rdf:type schema:ScholarlyArticle
61 N02a29daadbf3432797fd4b78d4d81948 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
62 schema:name Dexamethasone
63 rdf:type schema:DefinedTerm
64 N06f8e752619e49f98b8f51507550aabb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
65 schema:name Melphalan
66 rdf:type schema:DefinedTerm
67 N0c81fe5f44444da2be14167521e50ce2 schema:issueNumber 11
68 rdf:type schema:PublicationIssue
69 N0ccb24daa0cd45d8b8e1c54fd0c31dcf rdf:first sg:person.015101675464.51
70 rdf:rest N836fb14e43e1405ab8368f255d294607
71 N0fc502e1ef6c4cc2acce8c6461b66981 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
72 schema:name Thalidomide
73 rdf:type schema:DefinedTerm
74 N194f2df7d9f443c1b18bf571be4bda75 rdf:first sg:person.0663277537.07
75 rdf:rest N90e2b9336bb04be3817d5071c01a4e14
76 N2231afd2d57f4343a87b8a42c3f04ec3 schema:name CHRU Hôpital Sud Médecine Interne, Rennes, France.
77 rdf:type schema:Organization
78 N23f0c7e8081d4ae4903d8855318c6596 schema:name nlm_unique_id
79 schema:value 8704895
80 rdf:type schema:PropertyValue
81 N42c439ffbe5b4cb9ac9319897ebc9e4f schema:name pubmed_id
82 schema:value 28373701
83 rdf:type schema:PropertyValue
84 N439ea8fc71324ba9aef9fc0677e3727b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
85 schema:name Female
86 rdf:type schema:DefinedTerm
87 N44a5863dca764e8eb1db829547650f4c rdf:first sg:person.0742510353.17
88 rdf:rest N8dcf75ad52ba4bd58c1fb0f3bae55dd8
89 N44a9676bf79f4d85bbdee4be7ba72937 rdf:first sg:person.01125032152.62
90 rdf:rest rdf:nil
91 N4b4154c2bc7347a1ad47c0473fcbbfcd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Antineoplastic Combined Chemotherapy Protocols
93 rdf:type schema:DefinedTerm
94 N4c3717fe86524ef4a0e364e14f9af2a1 schema:name readcube_id
95 schema:value 4089e22ad7cc52bd30cd0a1a07b12bd9a145a3a59ad5fca73610cf93390e5a60
96 rdf:type schema:PropertyValue
97 N4e3ea0f23d374daea2add26261e70e34 schema:name dimensions_id
98 schema:value pub.1084510691
99 rdf:type schema:PropertyValue
100 N5705b6b6481c4788a7d845e72772045a rdf:first sg:person.0771317052.95
101 rdf:rest Nd4f6b6b3b8b44a27a0cb477b85499939
102 N5fb710815e77499ba0e9df74e0761a2f rdf:first sg:person.01012164172.15
103 rdf:rest Nb0a2cef9e31f444da019d3ab0d9221b4
104 N610959e30a8745e2984c801090c6be16 schema:name H. Hart Ziekenhuis Roeselare-Menen, Roeselare, Belgium.
105 rdf:type schema:Organization
106 N6382018fb4f246e3a613fd414f5e3ab8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Aged, 80 and over
108 rdf:type schema:DefinedTerm
109 N76ab5481ae1f40e78923757cb77e8cde schema:volumeNumber 31
110 rdf:type schema:PublicationVolume
111 N76b8fbbb00c34679b98400fb5206fd52 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Humans
113 rdf:type schema:DefinedTerm
114 N7b71989336824c77b441fb3bdfbec7a4 rdf:first sg:person.0611013300.29
115 rdf:rest N44a5863dca764e8eb1db829547650f4c
116 N7d236fdece634ba7975e25aeadbdf235 rdf:first sg:person.01031540525.68
117 rdf:rest Nbca139fc828f48d68878e714f96295b8
118 N7d6dc5bdd7a7490e8eee0512bc1c7b86 schema:name doi
119 schema:value 10.1038/leu.2017.111
120 rdf:type schema:PropertyValue
121 N836fb14e43e1405ab8368f255d294607 rdf:first sg:person.01276375576.23
122 rdf:rest N9ac62a8c4fb049c9b7f25fae6792e25b
123 N8dcf75ad52ba4bd58c1fb0f3bae55dd8 rdf:first sg:person.0760250477.44
124 rdf:rest N44a9676bf79f4d85bbdee4be7ba72937
125 N8f8c9206637f4af99686b3ddd9bcb44f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Adult
127 rdf:type schema:DefinedTerm
128 N90e2b9336bb04be3817d5071c01a4e14 rdf:first sg:person.01346655130.17
129 rdf:rest Ne325aa6d346247cc83eac843b9417ae5
130 N971a3cfd00174c1180c10d20419ea975 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Prednisone
132 rdf:type schema:DefinedTerm
133 N99501b32feb64f23b94a6fe0e969f89b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Middle Aged
135 rdf:type schema:DefinedTerm
136 N9ac62a8c4fb049c9b7f25fae6792e25b rdf:first sg:person.01246300414.38
137 rdf:rest Ne86acbe0d3cb4cd8b517a036907c6b25
138 N9db5f6a482db4c988bc4956178b63218 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Aged
140 rdf:type schema:DefinedTerm
141 N9de890d48b5d4266a6f5923471ce44b4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Multiple Myeloma
143 rdf:type schema:DefinedTerm
144 Nb0a2cef9e31f444da019d3ab0d9221b4 rdf:first sg:person.0765250665.41
145 rdf:rest N5705b6b6481c4788a7d845e72772045a
146 Nbca139fc828f48d68878e714f96295b8 rdf:first Nf7c2493905fc4cef81bab6d855caeb40
147 rdf:rest N7b71989336824c77b441fb3bdfbec7a4
148 Nc494f514590b4c0ca3ea9ddf191fe560 schema:affiliation https://www.grid.ac/institutes/grid.413396.a
149 schema:familyName Granell
150 schema:givenName M
151 rdf:type schema:Person
152 Nd28e8b4eff214ac2bf402df61747eb38 rdf:first sg:person.01002216441.96
153 rdf:rest N0ccb24daa0cd45d8b8e1c54fd0c31dcf
154 Nd4f6b6b3b8b44a27a0cb477b85499939 rdf:first sg:person.0600616433.10
155 rdf:rest Nd28e8b4eff214ac2bf402df61747eb38
156 Ndbd4ecffe73b4497ab81a96225a5ccb5 rdf:first sg:person.016600345354.31
157 rdf:rest N7d236fdece634ba7975e25aeadbdf235
158 Ndc4c35eb54b24b97b657e13a583c6ba9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Male
160 rdf:type schema:DefinedTerm
161 Ne325aa6d346247cc83eac843b9417ae5 rdf:first sg:person.016613112373.61
162 rdf:rest Ndbd4ecffe73b4497ab81a96225a5ccb5
163 Ne86acbe0d3cb4cd8b517a036907c6b25 rdf:first Nc494f514590b4c0ca3ea9ddf191fe560
164 rdf:rest N194f2df7d9f443c1b18bf571be4bda75
165 Nf7c2493905fc4cef81bab6d855caeb40 schema:affiliation https://www.grid.ac/institutes/grid.476819.5
166 schema:familyName Guthrie
167 schema:givenName T H
168 rdf:type schema:Person
169 Nfcd42e26276e4a8281b0842f99cf6402 schema:name Springer Nature - SN SciGraph project
170 rdf:type schema:Organization
171 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
172 schema:name Medical and Health Sciences
173 rdf:type schema:DefinedTerm
174 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
175 schema:name Clinical Sciences
176 rdf:type schema:DefinedTerm
177 sg:journal.1097065 schema:issn 0887-6924
178 1476-5551
179 schema:name Leukemia
180 rdf:type schema:Periodical
181 sg:person.01002216441.96 schema:affiliation https://www.grid.ac/institutes/grid.420748.d
182 schema:familyName Desjardins
183 schema:givenName P
184 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01002216441.96
185 rdf:type schema:Person
186 sg:person.01012164172.15 schema:affiliation https://www.grid.ac/institutes/grid.413574.0
187 schema:familyName Bahlis
188 schema:givenName N J
189 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01012164172.15
190 rdf:type schema:Person
191 sg:person.01031540525.68 schema:affiliation https://www.grid.ac/institutes/grid.416051.7
192 schema:familyName Basu
193 schema:givenName S
194 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01031540525.68
195 rdf:type schema:Person
196 sg:person.01125032152.62 schema:affiliation https://www.grid.ac/institutes/grid.413875.c
197 schema:familyName Facon
198 schema:givenName T
199 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01125032152.62
200 rdf:type schema:Person
201 sg:person.01246300414.38 schema:affiliation https://www.grid.ac/institutes/grid.414028.b
202 schema:familyName de Revel
203 schema:givenName T
204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01246300414.38
205 rdf:type schema:Person
206 sg:person.01276375576.23 schema:affiliation N2231afd2d57f4343a87b8a42c3f04ec3
207 schema:familyName Decaux
208 schema:givenName O
209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01276375576.23
210 rdf:type schema:Person
211 sg:person.01346655130.17 schema:affiliation https://www.grid.ac/institutes/grid.24381.3c
212 schema:familyName Nahi
213 schema:givenName H
214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01346655130.17
215 rdf:type schema:Person
216 sg:person.015101675464.51 schema:affiliation https://www.grid.ac/institutes/grid.418443.e
217 schema:familyName Stoppa
218 schema:givenName A-M
219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015101675464.51
220 rdf:type schema:Person
221 sg:person.016600345354.31 schema:affiliation https://www.grid.ac/institutes/grid.412094.a
222 schema:familyName Huang
223 schema:givenName S-Y
224 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016600345354.31
225 rdf:type schema:Person
226 sg:person.016613112373.61 schema:affiliation N610959e30a8745e2984c801090c6be16
227 schema:familyName Demuynck
228 schema:givenName H
229 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016613112373.61
230 rdf:type schema:Person
231 sg:person.0600616433.10 schema:affiliation https://www.grid.ac/institutes/grid.16821.3c
232 schema:familyName Shen
233 schema:givenName Z-X
234 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0600616433.10
235 rdf:type schema:Person
236 sg:person.0611013300.29 schema:affiliation https://www.grid.ac/institutes/grid.418722.a
237 schema:familyName Ervin-Haynes
238 schema:givenName A
239 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0611013300.29
240 rdf:type schema:Person
241 sg:person.0663277537.07 schema:affiliation https://www.grid.ac/institutes/grid.42399.35
242 schema:familyName Marit
243 schema:givenName G
244 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0663277537.07
245 rdf:type schema:Person
246 sg:person.0742510353.17 schema:affiliation https://www.grid.ac/institutes/grid.418722.a
247 schema:familyName Marek
248 schema:givenName J
249 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0742510353.17
250 rdf:type schema:Person
251 sg:person.0760250477.44 schema:affiliation https://www.grid.ac/institutes/grid.418722.a
252 schema:familyName Chen
253 schema:givenName G
254 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0760250477.44
255 rdf:type schema:Person
256 sg:person.0765250665.41 schema:affiliation https://www.grid.ac/institutes/grid.8982.b
257 schema:familyName Corso
258 schema:givenName A
259 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0765250665.41
260 rdf:type schema:Person
261 sg:person.0771317052.95 schema:affiliation https://www.grid.ac/institutes/grid.275559.9
262 schema:familyName Mugge
263 schema:givenName L-O
264 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0771317052.95
265 rdf:type schema:Person
266 sg:pub.10.1038/leu.2010.313 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034730993
267 https://doi.org/10.1038/leu.2010.313
268 rdf:type schema:CreativeWork
269 sg:pub.10.1038/leu.2013.220 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017507834
270 https://doi.org/10.1038/leu.2013.220
271 rdf:type schema:CreativeWork
272 sg:pub.10.1038/leusup.2013.5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025142681
273 https://doi.org/10.1038/leusup.2013.5
274 rdf:type schema:CreativeWork
275 sg:pub.10.1038/sj.leu.2404284 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033553106
276 https://doi.org/10.1038/sj.leu.2404284
277 rdf:type schema:CreativeWork
278 https://doi.org/10.1002/cncr.23546 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031068927
279 rdf:type schema:CreativeWork
280 https://doi.org/10.1016/s0140-6736(07)61537-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037699397
281 rdf:type schema:CreativeWork
282 https://doi.org/10.1056/nejmoa0801479 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043382081
283 rdf:type schema:CreativeWork
284 https://doi.org/10.1056/nejmoa1402551 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048449895
285 rdf:type schema:CreativeWork
286 https://doi.org/10.1155/2014/456037 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041179576
287 rdf:type schema:CreativeWork
288 https://doi.org/10.1182/blood-2009-03-211953 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019111246
289 rdf:type schema:CreativeWork
290 https://doi.org/10.1182/blood-2010-09-307645 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019656561
291 rdf:type schema:CreativeWork
292 https://doi.org/10.1182/blood-2011-02-338665 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042868402
293 rdf:type schema:CreativeWork
294 https://doi.org/10.1182/blood-2014-01-550020 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041943451
295 rdf:type schema:CreativeWork
296 https://doi.org/10.1200/jco.2008.21.0948 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040245441
297 rdf:type schema:CreativeWork
298 https://doi.org/10.1200/jco.2012.41.6180 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048463328
299 rdf:type schema:CreativeWork
300 https://doi.org/10.1200/jco.2013.49.0086 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026808845
301 rdf:type schema:CreativeWork
302 https://doi.org/10.3324/haematol.2009.015917 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031130867
303 rdf:type schema:CreativeWork
304 https://doi.org/10.3816/clml.2010.n.120 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013210054
305 rdf:type schema:CreativeWork
306 https://doi.org/10.6004/jnccn.2013.0007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078673181
307 rdf:type schema:CreativeWork
308 https://www.grid.ac/institutes/grid.16821.3c schema:alternateName Shanghai Jiao Tong University
309 schema:name Ruijin Hospital, Shanghai Jiao Tong University, Shanghai, China.
310 rdf:type schema:Organization
311 https://www.grid.ac/institutes/grid.24381.3c schema:alternateName Karolinska University Hospital
312 schema:name Karolinska University Hospital, Huddinge, Sweden.
313 rdf:type schema:Organization
314 https://www.grid.ac/institutes/grid.275559.9 schema:alternateName Jena University Hospital
315 schema:name Universitätsklinikum Jena Klinik für Innere Medizin II, Jena, Germany.
316 rdf:type schema:Organization
317 https://www.grid.ac/institutes/grid.412094.a schema:alternateName National Taiwan University Hospital
318 schema:name National Taiwan University Hospital, Taipei City, Taiwan.
319 rdf:type schema:Organization
320 https://www.grid.ac/institutes/grid.413396.a schema:alternateName Hospital de Sant Pau
321 schema:name Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
322 rdf:type schema:Organization
323 https://www.grid.ac/institutes/grid.413574.0 schema:alternateName Alberta Health Services
324 schema:name Tom Baker Cancer Center-University of Calgary, Calgary, Alberta, Canada.
325 rdf:type schema:Organization
326 https://www.grid.ac/institutes/grid.413875.c schema:alternateName Hôpital Claude Huriez
327 schema:name Service des Maladies du Sang, Hôpital Claude Huriez, CHRU Lille, Lille, France.
328 rdf:type schema:Organization
329 https://www.grid.ac/institutes/grid.414028.b schema:alternateName Hôpital d'instruction des Armées Percy
330 schema:name Hôpital d'Instruction des Armées PERCY, Paris, France.
331 rdf:type schema:Organization
332 https://www.grid.ac/institutes/grid.416051.7 schema:alternateName New Cross Hospital
333 schema:name New Cross Hospital, Wolverhampton, UK.
334 rdf:type schema:Organization
335 https://www.grid.ac/institutes/grid.418443.e schema:alternateName Institute Paoli-Calmettes
336 schema:name Institut Paoli Calmettes, Marseille, France.
337 rdf:type schema:Organization
338 https://www.grid.ac/institutes/grid.418722.a schema:alternateName Celgene (United States)
339 schema:name Celgene Corporation, Summit, NJ, USA.
340 rdf:type schema:Organization
341 https://www.grid.ac/institutes/grid.420748.d schema:alternateName Hopital Charles-LeMoyne
342 schema:name Hôpital Charles LeMoyne, Longueuil, Canada.
343 rdf:type schema:Organization
344 https://www.grid.ac/institutes/grid.42399.35 schema:alternateName Centre Hospitalier Universitaire de Bordeaux
345 schema:name CHRU Hôpital du Haut Lévêque, CHU de Bordeaux, Pessac, France.
346 rdf:type schema:Organization
347 https://www.grid.ac/institutes/grid.476819.5 schema:alternateName 21st Century Oncology (United States)
348 schema:name 21st Century Oncology, Jacksonville, FL, USA.
349 rdf:type schema:Organization
350 https://www.grid.ac/institutes/grid.8982.b schema:alternateName University of Pavia
351 schema:name Policlinico San Matteo Universita Di Pavia, Pavia, Italy.
352 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...